The latest news from the global pharmaceutical industry. Below you will find news and information to keep you up-to-date with what is happening in your industry. Coverage includes regulatory approvals, recall announcements, mergers and acquisitions, personnel news and appointments, new facility and facility expansion updates, collaborations and agreements, and financial updates.
The FDA has broadened the scope of the existing EUA for remdesivir to include treatment of all hospitalized patients with COVID-19.
read more
Mylan and Biocon announced the U.S. launch of Semglee in vial and pre-filled pen presentations, approved to help control high blood sugar with type 1 ...
read more
Tuesday, September 01, 2020
MediciNova announced development progress on its intranasal SARS-CoV-2 vaccine for COVID-19 utilizing BC-PIV, a viral vector platform technology ...
read more
Wednesday, September 02, 2020
Micron recently received a second tranche of funding to continue development of its microneedle-based technology for measles and rubella vaccination.
read more
Friday, September 04, 2020
AstraZeneca Pharmaceuticals
AMRI has signed a supply agreement with AstraZeneca to support the manufacture of AstraZeneca’s COVID-19 vaccine candidate AZD1222, intended to ...
read more
Monday, September 07, 2020
Abbott has announced the start of the LIFE-BTK clinical trial to evaluate the safety and effectiveness of the company's new Esprit™ BTK Everolimus ...
read more
Thursday, September 10, 2020
Review the latest news and information on the Coronavirus Pandemic.
read more
Friday, September 11, 2020
REGENXBIO announced the first patient has been dosed in the AAVIATE trial to evaluate the suprachoroidal delivery of RGX-314 using the SCS ...
read more
Monday, September 14, 2020
Direct Biologics announced the launch of their trial examining the use of ExoFlo extracellular vesicles to treat COVID-19 ARDS.
read more
Wednesday, September 16, 2020
AXON Neuroscience announced positive pre-clinical results for ACvac1, its vaccine candidate against novel coronavirus SARS-CoV-2.
read more
Wednesday, September 16, 2020
Biohaven reported the FDA has authorized initiation of trials for oral zavegepant and the company has achieved first in human dosing in a Phase 1 ...
read more
Friday, September 25, 2020
The FDA is alerting health care professionals and patients of a voluntary recall of all unexpired albuterol sulfate inhalation aerosol manufactured by...
read more
Monday, September 28, 2020
MediciNova announced its intranasal SARS-CoV-2 vaccine prototype for COVID-19, using BC-PIV technology, successfully induced systemic serum IgG and ...
read more
Tuesday, September 29, 2020
Bausch Health, Bausch + Lomb, and Eton announced the FDA has approved Alaway Preservative Free ophthalmic solution, 0.035%, antihistamine eye drops.
read more
Wednesday, September 30, 2020
CSL Behring announced the FDA has approved an expanded indication for HAEGARDA for routine prophylaxis to prevent HAE attacks in patients 6 years of ...
read more